interferon gamma
Trials 27 · a red edge is where a trial was stopped
Also used as a comparator or background therapy in 3 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00006113 Background | Jun 1999 → May 2003 | cutaneous melanoma | University of Southern California | Terminated | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT03984890 Background | Aug 2019 → Dec 2021 | chronic granulomatous disease | Children's Hospital of Fudan University | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT01649921 Comparator | Nov 2012 → Dec 2016 | infectious disease with sepsis | Radboud University Medical Center | Completed | No outcome recorded |
Evidence & citations 19 cited values
Every value below carries the sentence it was read from. 32 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | interferon gamma | “Recombinant interferon-gamma is a genetically engineered form of a substance normally produced by the body and is used to boost immune function.” NCT00001407 ↗28“Evaluating the Safety and the Biological Effects of Intratumoral Interferon Gamma and a Peptide-Based Vaccine in Patients With Melanoma” NCT00977145 ↗ “a single injection of DNX-2401 was followed by interferon gamma (IFN-γ).” NCT02197169 ↗ “Anti-tuberculosis drugs, interferon-gamma” NCT03984890 ↗ |
| Known as | gamma interferon | “In one or two patients on the drug, blood will be drawn frequently following one injection of gamma interferon (just before the injection and again at 0.25, 0.5, 1, 6, 12, 18,...” NCT00001407 ↗ |
| Known as | IFN-G | “Tumor Necrosis Factor (Knoll), TNF, NSC-635257; Interferon gamma (Genentech), IFN-G, NSC-600662.” NCT00001296 ↗5“IFN-g (interferon-gamma) 3 x 100 - 150 µg/week s.c. has been succesfully administered.” NCT00244179 ↗ “Interferon gamma human recombinant (IFN-G)” NCT05378646 ↗ “Interferon gamma human recombinant (IFN-G)” NCT05054114 ↗ “Interferon gamma human recombinant (IFN-G)” NCT05156541 ↗ “interferon gamma (IFN-G)” NCT00002637 ↗ |
| Known as | IFN-gamma | “Recently, it has been shown that in vivo administration of interferon gamma (IFN-gamma) upregulates CD18 expression in normals and alters leukocyte trafficking.” NCT00001905 ↗ |
| Known as | IFN-y | “HIV gag-pol antigens and interferon-gamma (IFN-y) in diluent” NCT00332930 ↗ |
| Known as | IFN-γ | “The administration of interferon gamma (IFNγ) can restore the level of mHLA-DR and may possibly improve the prognosis as an adjuvant therapy associated to antibiotics.” NCT05843786 ↗3“adjunctive immune-stimulatory therapy with interferon-gamma (IFN-γ) may represent a promising candidate” PMID 24669841 ↗ Mar 2014 “a single injection of DNX-2401 was followed by interferon gamma (IFN-γ).” NCT02197169 ↗ “Interferon-gamma (IFN-γ): starting dose 50 mcg/m2 subcutaneously” NCT02614456 ↗ |
| Known as | Immukine | “Interferon-gamma (Immukine, Boehringer-Ingelheim, Alkmaar, the Netherlands), 100mcg subcutaneously, on days 0-2-4-7-9-11.” NCT01649921 ↗ |
| Known as | Interferon gamma human recombinant | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05156541 ↗ |
| Known as | interferon gamma-1b | “Group 1 will receive 500 micrograms of interferon gamma-1b 3 times a week for 48 weeks by inhalation.” NCT00021567 ↗ |
| Known as | NSC-600662 | “Tumor Necrosis Factor (Knoll), TNF, NSC-635257; Interferon gamma (Genentech), IFN-G, NSC-600662.” NCT00001296 ↗ |
| Known as | recombinant interferon gamma | “Biological: recombinant interferon gamma” NCT00004032 ↗ |
| Known as | recombinant interferon gamma 1b | “recombinant interferon gamma 1b (rIFN-gamma1b)” PMID 19264351 ↗ Mar 2009 |
| Known as | rIFN-g | “rIFN-g (Interferon Gamma)” NCT00501644 ↗ |
| Known as | rIFN-gamma1b | “interferon gamma 1b (rIFN-gamma1b)” PMID 19264351 ↗ Mar 2009 |
| Known as | rIFN-γ | “treated with recombinant IFN-γ (rIFN-γ, 100 μg s.c., thrice a week) for 2 weeks” PMID 24669841 ↗ Mar 2014 |
| Known as | TG1041 | “Adenovirus-Interferon- Gamma (TG1041)” NCT00004016 ↗ |
| Action | Activate | “interferon gamma (IFN-gamma) upregulates CD18 expression in normals” NCT00001905 ↗ |
| Modality | Protein / enzyme biologic | “Recombinant Human Gamma Interferon” NCT00001317 ↗ |
| Route | Subcutaneous | “subcutaneous injections of interferon-gamma” NCT00001317 ↗ |